Health Care & Life Sciences » Pharmaceuticals | Relevium Technologies Inc.

Relevium Technologies Inc. | Balance Sheet

Fiscal year is July-June. All values CAD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
57.20
52.10
909.60
2,080.10
Total Accounts Receivable
37.00
84.90
119.10
143.50
Inventories
-
18.00
-
348.20
Other Current Assets
40.00
29.00
9.80
255.10
Total Current Assets
134.20
184.00
1,038.50
2,826.80
Long-Term Note Receivable
250.00
-
-
-
Intangible Assets
-
819.60
-
5,731.50
Other Assets
-
-
6,076.70
-
Total Assets
384.20
1,003.70
7,115.20
8,575.30
ST Debt & Current Portion LT Debt
-
-
25.40
Other Current Liabilities
236.90
437.20
1,260.30
Total Current Liabilities
236.90
437.20
1,285.70
Long-Term Debt
-
-
4,136.00
Other Liabilities
-
9.80
-
Total Liabilities
236.90
447.00
5,421.70
Common Equity (Total)
147.30
556.70
1,693.40
Total Shareholders' Equity
147.30
556.70
1,693.40
Total Equity
147.30
556.70
1,693.40
Liabilities & Shareholders' Equity
384.20
1,003.70
7,115.20

About Relevium Technologies

View Profile
Address
1000 Sherbrooke Street West
Montréal Québec H3A 3G4
Canada
Employees -
Website http://www.releviumcorp.com
Updated 07/08/2019
Relevium Technologies, Inc. develops medical devices for magnetic therapy. It focuses in musculoskeletal function specifically in the areas of pain relief, recovery and performance enhancement. The company was founded on July 19, 2012 and is headquartered in Montréal, Canada.